Johnson & Johnson (JNJ)
U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated
U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated
MIND TECHNOLOGY, INC. REPORTS FISCAL 2026 SECOND QUARTER RESULTS
Brookdale Senior Living Inc. - Brookdale Reports August 2025 Occupancy